The incidence of allergic diseases has dramatically increased in the last decades. The dysregulation of our immune systems ...
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, May 6, 2026 to report its first quarter 2026 financial ...
The study is testing GLK-321, an eye drop drug, in several dose levels. It aims to lower signs and symptoms of Demodex blepharitis and could become a new product in Glaukos’ growing eye care pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results